A carregar...
Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
Site-specific antibody conjugations generate homogeneous antibody-drug conjugates with high therapeutic index. However, there are limited examples for producing the site-specific conjugates with a drug-to-antibody ratio (DAR) greater than two, especially using engineered cysteines. Based on availabl...
Na minha lista:
| Publicado no: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8308878/ https://ncbi.nlm.nih.gov/pubmed/34358098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14070672 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|